<DOC>
	<DOC>NCT01996644</DOC>
	<brief_summary>This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication) augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be reduced more in the DCS relative to placebo condition (c) participants in the DCS condition will have a greater increase in Body Mass Index.</brief_summary>
	<brief_title>A Double Blind Clinical Trial of DCS for Food Anxiety</brief_title>
	<detailed_description />
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Diagnosed with Anorexia Nervosa, Bulimia Nervosa, Eating Disorder Not Otherwise Specified Pregnant or planning on becoming pregnant Psychotic or Manic</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Anorexia, Bulimia, Eating disorder, Anxiety, Exposure Therapy</keyword>
</DOC>